Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug;25(8):836-849.
doi: 10.1111/resp.13780. Epub 2020 Feb 16.

Identification and definition of asthma-COPD overlap: The CanCOLD study

Miriam Barrecheguren  1   2 , Lancelot Pinto  1 , Seyed-Mohammad-Yousof Mostafavi-Pour-Manshadi  1 , Wan C Tan  3 , Pei Z Li  1 , Shawn D Aaron  4 , Andrea Benedetti  1 , Kenneth R Chapman  5 , Brandie Walker  6 , J Mark Fitzgerald  3 , Paul Hernandez  7 , François Maltais  8 , Darcy D Marciniuk  9 , Denis E O'Donnell  10 , Don D Sin  3 , Jean Bourbeau  1 ; CanCOLD Collaborative Research Group and the Canadian Respiratory Research Network
Affiliations
Free article

Identification and definition of asthma-COPD overlap: The CanCOLD study

Miriam Barrecheguren et al. Respirology. 2020 Aug.
Free article

Abstract

Background and objective: Lack of consensus on diagnosis of ACO limits our understanding of the impact, management and outcomes of ACO. The present observational study aims to describe the prevalence, clinical characteristics and course of individuals with ACO based on various definitions used in clinical practice.

Methods: We included individuals with COPD from the prospective, multisite CanCOLD study and defined subjects with ACO using seven definitions commonly used in the literature.

Results: Data including questionnaires, lung function and CT scans were analysed from 522 individuals with COPD who were randomly recruited from the population. Among them, 264 fulfilled at least one of the seven definitions of ACO. Prevalence of ACO varied from 3.8% to 31%. Regardless of the definition, individuals with ACO had worse outcomes (lung function and higher percentage of fast decliners, symptoms and exacerbations, health-related quality of life and comorbidities) than the remaining patients with COPD. Conversely, patients with non-ACO had higher emphysema and bronchiolitis scores. The three definitions that included atopy and/or physician diagnosis of asthma identified subjects who differed significantly from patients with COPD. The two ACO definitions with post-bronchodilator reversibility were concordant with COPD and were the least stable, with less than 50% of the patients from each group maintaining reversibility over visits.

Conclusion: Atopy and physician-diagnosed asthma are more distinguishing characteristics to identify ACO. This finding needs to be validated using measures of airway inflammation and other specific biomarkers.

Trial registration: ClinicalTrials.gov NCT00920348.

Keywords: asthma and chronic obstructive pulmonary disease overlap; features; outcomes; phenotype.

PubMed Disclaimer

Comment in

References

REFERENCES

    1. O'Donnell DE, Aaron S, Bourbeau J, Hernandez P, Marciniuk DD, Balter M, Ford G, Gervais A, Goldstein R, Hodder R et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update. Can. Respir. J. 2007; 14(Suppl. B): 5B-32B.
    1. Christenson SA, Steiling K, van den Berge M, Hijazi K, Hiemstra PS, Postma DS, Lenburg ME, Spira A, Woodruff PG. Asthma-COPD overlap. Clinical relevance of genomic signatures of type 2 inflammation in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2015; 191: 758-66.
    1. Hardin M, Silverman EK, Barr RG, Hansel NN, Schroeder JD, Make BJ, Crapo JD, Hersh CP, COPDGene Investigators. The clinical features of the overlap between COPD and asthma. Respir. Res. 2011; 12: 127.
    1. Menezes AMB, Montes de Oca M, Pérez-Padilla R, Nadeau G, Wehrmeister FC, Lopez-Varela MV, Muiño A, Jardim JRB, Valdivia G, Tálamo C; PLATINO Team. Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype. Chest 2014; 145: 297-304.
    1. Rhee CK, Yoon HK, Yoo KH, Kim YS, Lee SW, Park YB, Lee JH, Kim Y, Kim K, Kim J et al. Medical utilization and cost in patients with overlap syndrome of chronic obstructive pulmonary disease and asthma. COPD 2014; 11: 163-70.

Publication types

Associated data